Search Results - "Ali Hosseini Rad, S M"

Refine Results
  1. 1

    Promoter choice: Who should drive the CAR in T cells? by Rad S. M., Ali Hosseini, Poudel, Aarati, Tan, Grace Min Yi, McLellan, Alexander D

    Published in PloS one (24-07-2020)
    “…Chimeric antigen receptor (CAR) T cell therapy is an effective treatment for B cell malignancies, with emerging potential for the treatment of other…”
    Get full text
    Journal Article
  2. 2

    Optimisation of Tet-On inducible systems for Sleeping Beauty-based chimeric antigen receptor (CAR) applications by Ali Hosseini Rad, S. M., Poudel, Aarati, Tan, Grace Min Yi, McLellan, Alexander D.

    Published in Scientific reports (04-08-2020)
    “…Regulated expression of genetic elements that either encode polypeptides or various types of functional RNA is a fundamental goal for gene therapy. Inducible…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Noise-Reduction and Sensitivity-Enhancement of a Sleeping Beauty-Based Tet-On System by Saunderson, Sarah C, Hosseini-Rad, SM Ali, McLellan, Alexander D

    Published in Genes (20-09-2022)
    “…Tetracycline-inducible systems are widely used control elements for mammalian gene expression. Despite multiple iterations to improve inducibility, their use…”
    Get full text
    Journal Article
  5. 5

    Implications of SARS-CoV-2 Mutations for Genomic RNA Structure and Host microRNA Targeting by Hosseini Rad Sm, Ali, McLellan, Alexander D

    “…The SARS-CoV-2 virus is a recently-emerged zoonotic pathogen already well adapted to transmission and replication in humans. Although the mutation rate is…”
    Get full text
    Journal Article
  6. 6

    The impact of non-synonymous mutations on miRNA binding sites within the SARS-CoV-2 NSP3 and NSP4 genes by Rad, S. M. Ali Hosseini, Wannigama, Dhammika Leshan, Hirankarn, Nattiya, McLellan, Alexander D.

    Published in Scientific reports (07-10-2023)
    “…Non-synonymous mutations in the SARS-CoV-2 spike region affect cell entry, tropism, and immune evasion, while frequent synonymous mutations may modify viral…”
    Get full text
    Journal Article
  7. 7

    Regulation of human Mcl-1 by a divergently-expressed antisense transcript by Ali Hosseini Rad, S.M., Min Yi Tan, Grace, Poudel, Aarati, He, Kevin, McLellan, Alexander D.

    Published in Gene (15-12-2020)
    “…•Mcl-1 expression is negatively regulated by an antisense transcript (Mcl1-AS1)•Mcl1-AS1 is predicted to bind to Mcl-1 mRNA.•The first exon and intron act as a…”
    Get full text
    Journal Article
  8. 8

    Compact Bidirectional Promoters for Dual-Gene Expression in a Sleeping Beauty Transposon by He, Kevin, Rad, S M Ali Hosseini, Poudel, Aarati, McLellan, Alexander Donald

    “…Promoter choice is an essential consideration for transgene expression in gene therapy. The expression of multiple genes requires ribosomal entry or skip…”
    Get full text
    Journal Article
  9. 9

    Optimization of anti-TIM3 chimeric antigen receptor with CD8α spacer and TNFR-based costimulation for enhanced efficacy in AML therapy by Pe, Kristine Cate S., Jewmoung, Sirirut, Rad, SM Ali Hosseini, Chantarat, Natthida, Chanswangphuwana, Chantiya, Tashiro, Haruko, Suppipat, Koramit, Tawinwung, Supannikar

    Published in Biomedicine & pharmacotherapy (01-10-2024)
    “…CAR T cell therapy for AML remains limited due to the lack of a proper target without on-target off-tumor toxicity. TIM3 is a promising target due to its high…”
    Get full text
    Journal Article
  10. 10

    Metabolic and Mitochondrial Functioning in Chimeric Antigen Receptor (CAR)-T Cells by Rad S M, Ali Hosseini, Halpin, Joshua Colin, Mollaei, Mojtaba, Smith Bell, Samuel W J, Hirankarn, Nattiya, McLellan, Alexander D

    Published in Cancers (11-03-2021)
    “…Chimeric antigen receptor (CAR) T-cell therapy has revolutionized adoptive cell therapy with impressive therapeutic outcomes of >80% complete remission (CR)…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18

    Development of a Multiepitope Vaccine Against SARS-CoV-2: Immunoinformatics Study by Ghafouri, Fatemeh, Ahangari Cohan, Reza, Samimi, Hilda, Hosseini Rad S M, Ali, Naderi, Mahmood, Noorbakhsh, Farshid, Haghpanah, Vahid

    Published in JMIR bioinformatics and biotechnology (19-07-2022)
    “…BackgroundSince the first appearance of SARS-CoV-2 in China in December 2019, the world witnessed the emergence of the SARS-CoV-2 outbreak. Due to the high…”
    Get full text
    Journal Article
  19. 19
  20. 20